1-9 of 9
Marcin Puto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Romidepsin in Conditioning and Maintenance Mitigates Relapse Risk and Enhances NK-Cell Cytotoxicity in Patients Receiving Allogeneic Stem Cell Transplant for Aggressive T-Cell Malignancies: Results of a Phase I/II Clinical Trial

Chitra Hosing, Zachary Braunstein, Alaa M Ali, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Karilyn Larkin, Sam Penza, Hannah Choe, Ayman Saad, Marcos J.G. de Lima, Lai Wei, Eric McLaughlin, Robin Nakkula, Amanda Campbell, Prashant Trikha, Marcin Puto, Basem M. William, Richard E. Champlin, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 553.
https://doi.org/10.1182/blood-2021-152833
Published: 2021
Journal Articles

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Joseph Maakaron, Qiuhong Zhao, Jayalakshmi Panicker Balakrishna, Marcin Puto, Wesley Ferguson, Sam Penza, Jonathan E Brammer, Kami J. Maddocks, Yvonne A. Efebera, Ayman Saad, Samantha Jaglowski, Basem M. William
Journal: Blood
Blood (2021) 138 (Supplement 1): 656.
https://doi.org/10.1182/blood-2021-149580
Published: 2021
Journal Articles

Phase I Dose-Escalation Study of Venetoclax Plus BEAM Followed By Autologous Stem Cell Transplant (ASCT) for Chemoresistant or High-Risk Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

Joseph Maakaron, MD, Qiuhong Zhao, MS, Marcin Puto, PharmD, Quinn Verfurth, Sam Penza, MD, Jonathan E Brammer, MD, Yvonne A. Efebera, MD MPH, Ashley E. Rosko, MD, Ayman Saad, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2024.
https://doi.org/10.1182/blood-2019-126994
Published: 2019
Journal Articles

Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS

Brendan Rasor, PharmD, Tyler Dickerson, PharmD, Qiuhong Zhao, MS, Jonathan E Brammer, MD, Karilyn Larkin, MD, Samantha Jaglowski, MDMPH, Alice S. Mims, MD, Sam Penza, MD, Sumithira Vasu, MDMBBS, Sarah A Wall, MD, Basem M. William, MRCP,MD, Ayman Saad, MD, Julianna Roddy, PharmD, Hannah K. Choe, MD, Marcin Puto, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5715.
https://doi.org/10.1182/blood-2019-123657
Published: 2019
Journal Articles

Impact of Cytokine Release Syndrome on Outcomes after T-Cell Replete Peripheral Blood Haploidentical Donor Transplantation

Caner Saygin, MD, John L Vaughn, MD, Joseph Coleman, Marcin Puto, PharmD, Julianna Roddy, PharmD, Sam Penza, MD, Jonathan E. Brammer, MD, Yvonne Efebera, MD, Don M. Benson, Jr., MD PhD, Sumithira Vasu, MD MBBS, Alison R. Walker, MD, Alice S. Mims, MD, Bhavana Bhatnagar, DO, Bradley Wayne Blaser, MD, Maria Chaudhry, MD, Hannah K. Choe, MD, Karilyn Larkin, MD, Meixiao Long, MD, Ashley E. Rosko, MD, Nicole Grieselhuber, MD PhD, Sarah A Wall, MD, Steven Devine, Samantha Jaglowski, MD MPH, Basem M. William, MRCP, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3357.
https://doi.org/10.1182/blood-2018-99-114100
Published: 2018
Journal Articles

Response Rates, Non-Relapse Mortality, and Financial Implications of Transplant-Associated Thrombotic Microangiopathy Treated with Eculizumab

John L Vaughn, MD, Qiuhong Zhao, MS, Parvathi Ranganathan, PhD, Patrick Elder, Basem M. William, MRCP,MD, Marcin Puto, PharmD, Julianna Roddy, PharmD, Rebecca Klisovic, William Blum, MD, Don M Benson, Jr., MD PhD, Samantha M. Jaglowski, MDMPH, Alice S. Mims, MD MSCR, Jonathan E. Brammer, MD, Bhavana Bhatnagar, DO, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH, Leslie A Andritsos, MD, Sam Penza, MD, Allison R. Walker, MD MPH, Steven M. Devine, MD, Spero R Cataland, MD, Sumithira Vasu, MDMBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1932.
https://doi.org/10.1182/blood.V130.Suppl_1.1932.1932
Published: 2017
Journal Articles

Transplant Associated Thrombotic Microangiopathy (TA-TMA) Commonly Occurs after Steroid-Refractory or Dependent Gastrointestinal (GI) Graft Versus Host Disease (GVHD) and Contributes to Post-Transplant Morbidity

Sarah A Wall, MD, Qiuhong Zhao, MS, Parvathi Ranganathan, PhD, Patrick Elder, Basem M. William, MD, Marcin Puto, PharmD, Julianna Roddy, PharmD, Rebecca B. Klisovic, MD, William Blum, MD, Don M Benson, Jr., MD PhD, Samantha Jaglowski, MD MPH, Alice S. Mims, MD MSCR, Jonathan E Brammer, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH, Leslie Andritsos, MD, Sam Penza, MD, Allison R. Walker, MD MPH, Steven M. Devine, MD, Spero R Cataland, MD, Sumithira Vasu, MDMBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 4483.
https://doi.org/10.1182/blood.V130.Suppl_1.4483.4483
Published: 2017
Journal Articles

Analysis of VDT-PACE Utilization in Multiple Myeloma Patients Treated at MSKCC for Relapsed Disease or Cytoreduction and Stem Cell Mobilization after Initial Induction Therapy

Kristen Beyer, PharmD, BCOP, Samuel Rosner, Kaitlin M Woo, MA, Sean M. Devlin, PhD, Heather Landau, MD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, David J Chung, MD PhD, Nelly G. Adel, PharmD, BCOP, BCPS, Marcin Puto, PharmD, BCOP, Ola Landgren, MD, PhD, Sergio Giralt, MD, Alexander M. Lesokhin, MD
Journal: Blood
Blood (2014) 124 (21): 3459.
https://doi.org/10.1182/blood.V124.21.3459.3459
Published: 2014
Journal Articles

The Use of Combination PACE Regimens for Patients with Relapsed and Refractory Multiple Myeloma (MM) and Their Impact on Stem Cell Transplantation (SCT)

Marcin Puto, Pharm.D., Nelly G. Adel, PharmD, BCOP, BCPS, Hani Hassoun, MD, Sergio Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2011) 118 (21): 5127.
https://doi.org/10.1182/blood.V118.21.5127.5127
Published: 2011